ARCHIVES

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

CGAP Speeding Gene Discovery

April 30, 1999

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

In Brief: Diagnostic Imaging Cost Declines By Half as Percentage Of Health Cost In 10 Years

January 11, 1985

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011